Randox Biosciences Resource Hub

Home - education

Randox Biosciences Resource Hub

Resource Hub | Biosciences

  • Brochures
  • Flyers
  • Videos

Biosciences overview

Immunology

Molecular Testing

CDx & Biopharma Services

Cardiovascular & Metabolic

Biosciences Bioreagents

Biosciences Overview Video

Drug Induced Kidney Injury panel

STI Campaign Video

Biochip Overview

Randox Multiplex Stroke Biochip

Acute Kidney Injury

Randox Coronavirus Biochip Video


Welcome to Vivasuite!

Vivasuite | The Digital Ecosystem for Vivalytic

Connectivity at the Point of care

 

 

Welcome to Vivasuite!

 

Enabling the management of multiple devices remotely, Vivasuite is the digital healthcare ecosystem  allowing users to stay up to date with the latest tests and system updates.

Register your interest

Running within the Bosch IoT cloud maintaining the highest standard of IT security and data privacy. Connectivity ensures that devices are always available and fully updated.

 

 

Advantages of Vivasuite:

 

– Schedule remote software updates

– Know when your devices were last synchronised

– View all devices in one dashboard

– View device information and general device data

View testing history from one system

– Mobile device monitoring

– Vivalytic user management

– Save time with less “on-device” work

Vivalytic Overview

Discover more about the Vivalytic

 

 


Vivalytic Resource Hub

Vivalytic | Resource Hub

Making a Point to Care

 

  • Brochures
  • Flyers
  • Videos
  • Scientific Papers

Vivalytic

VIVALYTIC MG, MH UP/UU Educational Guide

VIVALYTIC MRSA/SA Educational Guide

Vivalytic Overview

Discover more about the Vivalytic

 

 

SARS-CoV-2 Dual Target, Flu A/B and RSV

SARS-CoV-2 Dual Target

Viral Respiratory Infection Array

Sexually Transmitted Infection Array

SARS-CoV-2 Pooling Test

MG, MH, UP/UU Rapid Test

SARS-CoV-2 Rapid Test

MRSA & MSSA Rapid Test

Randox Vivalytic

Vivalytic Installation & Operator User Guide

Vivalytic: Instructional Promo Video

Vivalytic: COVID-19 Testing Process

Coronavirus Testing on the Vivalytic POC Analyser

EVALUATION OF A MULTIPLEX REAL-TIME PCR ASSAY FOR THE DIAGNOSIS OF SEXUALLY-TRANSMITTED INFECTIONS

RAPID AND ACCURATE DETECTION OF MYCOPLASMATACEAE IN CLINICAL SAMPLES


What We Do: Cutting-Edge Healthcare Diagnostics

About Randox

You may already be familiar with Randox! Not only do we sponsor the world’s greatest race, the Randox Grand National, we also have a range of sporting partnerships including Team GB, Olimpia Milano basketball team and more. Or perhaps you recognise the name as being one of the partners in the UK Government’s testing programme for COVID-19.

Disruptive Innovation in Diagnostics and Healthcare

Randox is dedicated to improving healthcare using innovative diagnostic technologies, for a range of health conditions including heart disease, diabetes, Alzheimer’s disease, cancer and stroke.

Whilst the science is complex, the applications are not. Diagnostic testing takes place every day behind the scenes of GP surgeries, laboratories and hospitals.

Around 70% of all medical decisions are based on laboratory results, and so, not surprisingly, we believe that earlier, more accurate and more accessible diagnostics are the key to improving global health and saving lives.

The Future of Healthcare

We are significantly increasing our UK High Street presence, using the unique national coronavirus testing infrastructure and capacity we invested in during the pandemic to deliver a new range of preventative health checks. Expansion plans will see up to 20 new Randox Health clinics operating in the UK and Northern Ireland by the end of the year. The clinics will provide easy access for millions to a range of diagnostic tests for vitamin deficiencies, hormone imbalances, inherited/genetic conditions and key health concerns including heart, liver and kidney conditions.

Key to the unique range of diagnostic testing available at our growing network of clinics is the testing technologies, facilities and comprehensive, nationwide distribution network rapidly developed by Randox Laboratories to play a key role in meeting the sudden national demand for Covid-19 PCR tests. At the height of the pandemic emergency, Randox were the only laboratory in the UK and Northern Ireland to process over 100,000 PCR tests per day, saving thousands of lives.

Now, with millions of people having become accustomed to regular testing through the pandemic, Randox is combining that familiarity with its own unique Covid-19 experience and infrastructure to deliver real, affordable and preventative healthcare through early diagnostic testing on the High Street.


“Randox believes that in harnessing the achievements of during the pandemic we can help the shift away from the traditional model of sickness management to a new era of truly preventative healthcare. This will benefit individuals and society by improving patient outcomes and considerably reducing the burden on our vital and hard-pressed clinical services” (Randox founder and Managing Director – Dr Peter FitzGerald).

Frequently Asked Questions?

  • What is the vision of Randox?

    The Randox ethos of improving healthcare, which drove our Managing Director Dr Peter FitzGerald to start the company in the 1980s, continues today. Up to 25% of our turnover is reinvested in research and development to enable our scientists to work on the development of pioneering tests for a range of common illnesses such as cancer, cardiovascular disease and Alzheimer’s disease.

    We have also spent more than £220 million developing our patented Randox Biochip.  This state-of-the-art biochip technology has revolutionised the diagnostics industry because it allows multiple tests to be carried out from a single, undivided patient sample on a single testing platform.

  • When and why was Randox established?

    Our Managing Director Dr FitzGerald established Randox in 1982 in County Antrim, Northern Ireland, to address the need for accurate and readily available diagnostic tests to improve patient diagnosis.  At that time, doctors only conducted a handful of tests per patient, but now, more than 40 years later, Randox has developed and improved hundreds of tests, with hundreds more in development.

  • What products and service do Randox offer?

    Randox has a broad range of products and services that offer a comprehensive insight into patient diagnosis to facilitate more effective disease management and treatment.

    Our clinical product offering includes diagnostic reagents, quality control, and clinical chemistry analysers.

    Our patented Randox Biochip Technology and associated Immunoassay analysers also have applications for forensic toxicology, food diagnostics, and workplace drug testing.

    Our Randox Health clinics offer a range of health checks across general health, sexual health, respiratory health and more. 

  • Who and where are Randox customers?

    Randox’s focus has traditionally been on healthcare providers, so we have placed our products and services in hospitals, clinics, research and molecular laboratories, food testing, forensic toxicology, life sciences and veterinary laboratories.

    With the establishment of our consumer brand, Randox Health, we also offer our innovative tests directly to the consumer in our Randox Health clinics, located across the UK including London, Liverpool, Manchester, Birmingham, Glasgow, Edinburgh, Holywood and Crumlin.

    We have ambitious plans to roll out a number of new clinics across the United Kingdom and internationally, over the coming months and years.

  • What is the size of the company?

    Our company has grown from a small team of two scientists, to over 3300 employees of 44 nationalities, including 650 research scientists and engineers.

     

  • Where are Randox headquartered and what is the geographical reach?

    Our headquarters are in Crumlin, in County Antrim, Northern Ireland – close to Belfast International Airport.  However, we are a global company and currently have offices and distribution outlets in 145 countries, with manufacturing and R&D capabilities in 4 jurisdictions across 3 continents.

    We are currently relocating our headquarters to the Randox Science Park in Antrim; a £161 million project which will accelerate the development of new products into a wide range of clinical needs, including various cancers, stroke, heart disease and neurodegenerative disorders.

    We are very proud of our global penetration – today, approximately 5% of the world’s population receives medical diagnoses using products from Randox.  That equates to about 400 million people. We also supply 15% of the world’s cholesterol tests, so if you’ve ever had your cholesterol checked,  then there’s a high chance it could have been performed using a Randox product!

  • What are the biggest issues within the health sector?

    Our key observation across the globe is that within healthcare the pressure on resources means there is a focus on the “management of sickness,” rather than preventative care. 

    We know that a focus on early diagnosis and preventative care will improve patient outcomes and reduce the burden on healthcare systems.  Making that paradigm shift is a major challenge.  

    That’s why Randox Health was established – to allow the consumer direct access to our innovative technologies so that they can take control of their health and make appropriate lifestyle changes BEFORE disease manifests and symptoms occur.

  • What is Randox doing in the fight against COVID-19?

    To find out more about our test and testing services for COVID-19, visit our COVID-19 FAQ page by clicking here.

Want to know more?

Contact us or visit our dedication to quality webpage.

Our History

Company Values

Our Accreditations


Randox QC Resource Hub

  • Brochures
  • Support Tools
  • Educational Items
  • Posters
  • Industry Articles
  • Webinars
  • Videos
  • Blog
  • Testimonials
The importance of third party controls brochure on the Randox Resource hub

Importance of Third Party Controls

Infectious Disease Controls (Serology)

Acusera Linearity Sets

IQC - Liquid 30 Day Controls

RIQAS External Quality Assessment

RIQAS Point of Care (RIQAS POC)

Qnostics - Molecular Infectious Disease Controls

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

Serum Indices

The Role of Six Sigma in a Modern QC Strategy

The Cost of Poor Quality in the Clinical Laboratory

How to Establish QC Reference Ranges

Basic QC Statistics

ISO 15189 Requirements for Measurement Uncertainty

Commutability

The Role of EQA in QC

Troubleshooting QC Errors

What Format Is Best For Your Laboratory - Download

What Format Is Best For Your Laboratory

Quality Control for POCT - Download

Quality Control for POCT

Importance of Third Party Controls in Molecular Infectious Disease Testing

Designing An Appropriate QC Design Procedure

Which QC is The Right QC - Downloads

Which QC is The Right QC

How Often Is Right For QC - Download

How Often Is Right For QC

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

RIQAS Frequency - Lipase

RIQAS Past Panels Flyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Why is the third party QC important for COVID-19 detection in Molecular testing

Importance of Third Party Controls in Molecular Diagnostics

Performance & Statistics - How EQA Can Help You Excel

RIQAS Report Interpretation

Importance of Third Party Controls in Molecular Diagnostics

Fully syndromic approach to molecular testing

Medlab- 24.7 Webinar with Patrick Else

SARS-CoV-2 Proficiency Testing

The Role of EQA in QC Management

Importance of EQA

The Need for Robust Molecular Quality Assurance in the Wake of the Pandemic

RIQAS Reporting

Utilisation of QC Software for Identification of Performance Issues

Acusera 24•7 Webinar: Utilisation of QC software and metrics to help identify performance issues

Acusera Third Party Controls

True Third Party Controls

Randox Acusera Quality Controls

Consolidation

QC Serology Video

Acusera 24.7 Live Online

Guide to Running Quality Control

Medical Lab Professionals Week 2016

Acusera 24•7 Interlaboratory Data Management

Acusera 247 Video

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Customer Testimonial | Dr Bianca Thakkar

Customer Testimonial | Dr. Anil Shah

Customer Testimonial | Dr Pragati Desai

Customer Testimonial | Dr Pramod Ingale

Customer Testimonial | Dr Rajeev Mehta

Customer Testimonial | Dr Simple Bhuptani

Customer Testimonial | Dr SM Patel

Customer Testimonial | Dr Trupti Patel

Customer Testimonial | Dr A Vahed Mulla


Randox sponsors Science Summer School Northern Ireland

About Randox       News        Contact Us

Monday 31st January 2022: Randox sponsors Science Summer School Northern Ireland

An official launch for Science Summer School Northern Ireland 2022 has taken place at the Ryobi headquarters in Carrickfergus.

Ryobi are the headline sponsor of the Science Summer School Northern Ireland event, which aims to inspire young people to become the next generation of scientists with an inspirational programme that mixes the best of STEAM (Science, Technology, Engineering, Arts and Maths) through a series of seminars, discussions and hands-on experiments.

On Friday, the Deputy Mayor of Mid and East Antrim, Lord Andrew Mawson OBE, Richard Mallett, and representatives from the other main sponsors, Terumo Blood and Cell Technologies, Randox, Almac, NRC and IPC Mouldings all gathered in Carrickfergus to officially launch the event which will take place later this year.

The Science Summer School initiative was established in 2012 at St. Paul’s Way Trust School in East London by Lord Andrew Mawson OBE and Professor Brian Cox CBE. The project is now expanding nationally with the aim to make ‘the UK the best place to do science and engineering in the world’.

Deputy Mayor, Councillor Matthew Armstrong, said:

 “Council’s Manufacturing Task Force are delighted to be working with a range of local businesses, schools, universities and partner organisations to bring this exciting opportunity to the borough.

“We are thrilled that this event is now going accessible to young people in Mid and East Antrim.

“Our hope is that they will be inspired to embark on a future in science and maybe even become leaders in that field.”

Managing Director of Ryobi, Marco Emig, said: 

 “Ryobi are delighted to be the headline sponsor of this event.

“Science and the desire to learn more about how our world works, and about how we can use that information to improve how we live our lives, has never been more attractive or relevant as a subject area and a potential career path.

“We are very much looking forward to seeing the creative ideas generated from our young people.”

Lord Mawson OBE said: 

 “The Science Summer School initiative here in Northern Ireland will activate the curiosities of the young people who take part and hopefully inspire them to great things.

“This annual celebratory event and the allied programme of STEAM related activity throughout the year provides a vital catalyst to bring together different partners from education and enterprise.  I am delighted to see so many companies have ‘signed up’ to support our first event this year.

 “There is never a better time to be bringing the Science School Northern Ireland hosted by Professor Cox to Ballymena.”

For further information please contact randoxpr@randox.com

Want to know more?

Contact us using the details below.

Related Pages

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


Evidence Series Resource Hub

Evidence Series | Resource Hub

  • Brochures
  • Flyers
  • Videos
  • Blogs
  • Scientific Posters
  • Whitepapers

Evidence

Evidence Investigator

Evidence MultiSTAT

Evidence+

Evidence Evolution

Biochip Technology Explained

Evidence series Overview

Discover more about the Evidence series

 

Cytokines Flyer

DIKI Renal Flyer

A4 Renal Flyer

AKI Covid-19 Flyer

Evidence Investigator - Molecular Diagnostic Testing

Evidence MultiSTAT Demonstration

Evidence Evolution - World's Most Advanced Immunoanalyser

Evidence Investigator - Myco 9 Array, Step By Step

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS DETECTION OF CANCER BIOMARKERS ON THE RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A DUPLEX BIOCHIP ASSAY FOR THE SIMULTANEOUS DETECTION OF ANTI-THYROGLOBULIN AND ANTI-THYROID PEROXIDASE ANTIBODIES ON THE FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF NEW BIOCHIP ARRAYS FOR THE DETERMINATION OF BIOMARKERS RELATED TO ACUTE KIDNEY INJURY APPLIED TO THE EVIDENCE INVESTIGATOR ANALYSER

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE DETECTION OF PARATHYROID HORMONE APPLIED TO THE EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A HIGHLY MULTIPLEXED MOLECULAR ASSAY FOR DETECTION OF INFECTION IN CF AIRWAYS

Repeatability and within-laboratory precision were assessed (n=80): Assay Repeatability Within-laboratory precision CV (%) CV (%) VCAM-1 4.5 6.8 ICAM-1 5.6 8.8 ESEL 12.8 16.6 PSEL 3.5 4.7 LSEL 5.7 8.2 17.096, 097.105RDRT DEVELOPMENT OF A BIOCHIP ARRAY FOR THE DETECTION OF ADHESION MOLECULES ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY UNAFFECTED BY DHEA-S INTERFERENCE FOR THE ACCURATE MEASUREMENT OF SERUM PROGESTERONE

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE RAPID, SIMULTANEOUS DETECTION OF PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17, ON THE NEW RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

CLINICAL EVALUATION OF A RAPID FULLY-AUTOMATED MULTIPLEX BIOCHIP ARRAY FOR STROKE DIAGNOSIS

DEVELOPMENT OF A NEW BIOCHIP ARRAY APPLIED TO THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER FOR THE SIMULTANEOUS MEASUREMENT OF TSH, FREE T4 AND FREE T3

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE MEASUREMENT OF TOTAL 25-HYDROXYVITAMIN D IN SERUM AND THE ACCURATE CLASSIFICATION OF VITAMIN D STATUS

DEVELOPMENT OF A BIOCHIP ASSAY FOR THE DETECTION OF THYROXINE-BINDING GLOBULIN (TBG) ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

GENETIC DIAGNOSIS OF MONOGENIC OR POLYGENIC FAMILIAL HYPERCHOLESTEROLEMIA IN NORTHERN IRELAND: EVALUATION OF THE RANDOX FH ARRAYS IN COMBINATION WITH THE RANDOX 6SNP POLYGENIC HYPERCHOLESTEROLEMIA ARRAY

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS MEASUREMENT OF DISTINCT FATTY ACID-BINDING PROTEINS (FABPs)

DEVELOPMENT OF A NEW ENZYME-LINKED IMMUNOSORBENT ASSAY KIT TO DETECT NGAL IN HUMAN SERUM AND ITS APPLICATION TO CHRONIC KIDNEY DISEASE

SCREENING AND SELECTION OF ANTIBODIES FOR THE DETECTION OF MIP-1 ALPHA AND ITS APPLICATION TO THE STUDY OF CHRONIC KIDNEY DISEASE

DEVELOPMENT OF A 4-PLEX BIOCHIP ARRAY FOR THE EARLY DETECTION OF CHRONIC KIDNEY DISEASE

DEVELOPMENT OF A THIRD GENERATION TSH ASSAY ON THE NEW RANDOM ACCESS EVIDENCE EVOLUTION FULLY AUTOMATED BIOCHIP ANALYSER

APPLICATION OF THE NEW RANDOM ACCESS, FULLY AUTOMATED BIOCHIP ANALYSER EVIDENCE EVOLUTION TO SIMULTANEOUSLY MEASURE ANALYTES RELATED TO ENDOCRINE FUNCTION

STRATIFYING RISK OF ACUTE KIDNEY INJURY IN PRE AND POST CARDIAC SURGERY PATIENTS USING A NOVEL BIOMARKER-BASED ALGORITHM AND CLINICAL RISK SCORE

SARS-CoV-2 Vascular & Multi-System Dysfunction


The use of DNA, Drug and Alcohol Testing in Medico-Legal cases

18 September 2020: The use of DNA, Drug & Alcohol Testing in Medico-Legal cases

Drug and alcohol testing may be required by various professional bodies involved in child custody cases, care proceedings or child protection cases. In cases regarding divorce and children, a dispute may arise during the process of discussions involving the custody of children. In these cases, drug and alcohol testing may be sought if there has been a substance abuse claim against a parent fighting for custody or visitation. In cases relating to child protection, social services may seek drug and alcohol testing if child welfare claims have been made regarding suspected substance misuse.

Why is Drug and Alcohol Testing in Medico-legal Cases Important?

Drug and alcohol testing is important to ensure child protection from the detrimental effects of parental substance misuse and to ensure they have the quality of life they deserve. In addition, it is also important to allow parents the opportunity to get the help and support they need and begin rehabilitation treatment.

Doing the right thing by the child is the main priority, and where possible parent and child relationships are sought to be maintained. Drug and alcohol testing assists in these efforts and in such cases abstinence monitoring testing may be required to assess a parent’s recovery e.g. if a visitation case is being reassessed.

Our Expertise

At Randox Testing Services we provide drug and alcohol testing to all professionals within the medico-legal sector. Our testing service utilises accredited testing methods and is made more cost-effective through patented testing methods developed by Randox.

We understand the impact a positive result can have on a parent, child, and extended family and ensure results are of the highest precision and accuracy. With over 35 years’ experience in the diagnostic industry we have gained reputation as a trusted provider.

Our drug and alcohol testing solutions are flexible and can be tailored to our customer needs with a choice of testing methods. We offer a comprehensive drugs of abuse test menu and our service also includes the use of an Expert Witness Statement where applicable.

Range of Testing

We provide a range of testing to suit the requirements for any medico-legal case. Read more below to find out what is available.

Alcohol Testing

PEth

PEth (Phosphatidylethanol) is a direct alcohol biomarker that only forms in the body when ethanol is present, making it the most sensitive and specific test to assess alcohol consumption levels.

  • PEth test involves spotting a drop of blood from a small finger prick onto a test card. The dried blood spot (DBS) is sent to the laboratory for analysis.
  • PEth testing will differentiate between abstinence or light alcohol consumption, social alcohol consumption and alcohol abuse for up to a month prior to the test.

Benefits of PEth Testing

  • Accurate blood alcohol test
  • Detect chronic and single-drinking episodes of alcohol consumption
  • Monitor abstinence, drinking behaviour and identify relapse

Hair Alcohol Testing

Testing for alcohol in head hair works by detecting two metabolites of alcohol: ethyl glucuronide (EtG) and the fatty acid ethyl ester (FAEE). Both EtG and FAEE can be measured in hair providing an insight into alcohol consumption over the previous period of months. Concentrations can be influenced by cosmetic treatments and products and as such it is always advisable to test in conjunction with PEth or LFT/CDT blood testing.

Benefits of Hair Alcohol Testing

  • Assessment of alcohol consumption for up to 6 months
  • Collected by fully trained Collection Officer
  • History of alcohol consumption can be established

Blood Alcohol Testing

Blood alcohol testing is used to measure the level of alcohol in an individual’s blood. When alcohol is consumed, it’s absorbed into the bloodstream, with approximately 90% being broken down into the liver. RTS offer the following blood alcohol tests:

  • Liver Function Test (LFT) – The blood is examined for specific enzymes which can indicate damage to the liver caused by alcohol consumption. However, other factors can lead to increased levels of liver enzymes.
  • Carbohydrate Deficient Transferrin (CDT) – Looks at specific protein which can become elevated because of heavy alcohol consumption. However, other factors can lead to increased levels of CDT.

Benefits of Blood Alcohol Testing

  • Collection by a fully trained phlebotomist collection officer
  • Assessment of alcohol consumption for up to 1 month
  • Determine drinking behaviour and patterns of use

Drug Testing

Urine

Urine drug testing is used to determine whether someone is misusing drugs by taking a sample of their urine. We offer a 12 panel that covers the major drug groups, including:

Opiates, MDMA/Ecstasy, Cocaine, Tramadol, Methadone, Methamphetamine, Ketamine, Amphetamine, Cannabinoids, EDDP, Benzodiazepines, Buprenorphine

Benefits of Urine Drug Testing

  • Assessment of substance consumption for up to 12 days, drug dependent and quantity ingested
  • Confirmation of presumptive positive available on request
  • Fully accredited LC mass spectrometry confirmatory analysis

Hair

Hair drug testing is a useful form of testing and can be used to support other methods such as oral fluid and urine testing. Our standard panel for hair drug testing includes:

Opiates, Methadone, Tramadol, Cocaine (inc. Crack Cocaine), Amphetamines, (inc. Methamphetamines and “ecstasy” type drugs), Benzodiazepines, Cannabis, Ketamine

Benefits of Hair Drug Testing

  • Detection window of 0-12 months dependent on length (1cm roughly 1 month) – Can be an overview of 3 monthly periods or segmented into monthly periods.
  • Head hair & body hair (except axillary & pubic)
  • Body hair – Up to a 12-month overview. Unable to be segmented
  • Bespoke hair drug panel with other substances available on request

DNA Testing

We provide a range of DNA Testing services to suit your requirements.

  • Paternity testing
  • Maternity testing
  • Sibling DNA testing
  • Grandparent DNA testing
  • Aunt/Uncle testing

Benefits of DNA Testing

  • Fully trained collection officer
  • Legally accepted results

Want to find out more?

To speak to one of our experts about how our range of testing and services can help with your medico-legal testing enquiry, contact us today by emailing testingservices@randox.com or by phoning +44 (0) 28 9445 1011

 

Want to know more?

Contact us or visit our website to read more.


Drug and Alcohol Training from Randox Testing Services

10 August 2020: Drug and Alcohol Training from Randox Testing Services

As well as providing a fully managed drug & alcohol testing service, RTS provide a range of training and education services to help inform and educate regarding the issue of drug & alcohol use in the workplace.

Alcohol use increases the risk of problems in the workplace, such as absenteeism, presenteeism and inappropriate behaviour. Use of alcohol or illicit drugs can impair a person’s performance at work through poor decision making and impaired reaction times causing lost productivity, inferior goods/services, errors and accidents.

Certain working situations and conditions are associated with use of alcohol and illicit drugs (i.e. shift or night work, travel away from home, working remotely, business meals, poor communications and job stress, etc). There are many factors within the workplace culture that present an increased risk for the use of substances including availability, work/peer-group pressures, lack of supervision, physical danger and interface with a demanding or aggressive public. International evidence also indicates that longer working hours are significantly associated with higher rates of alcohol use and related problems.

Professional Services

Randox Testing Services offer professional training services to ensure efficient implementation of workplace drug and alcohol testing. The training services confirm employer confidence to carry out workplace drug and alcohol testing and management competence in enforcing the process. There are a range of tailored training programmes to educate employers and their management staff.

Range of Courses

Our range of competency courses are designed to train employees who will be responsible for carrying out self-collection in accordance with company policy. Anyone involved in self-collection needs to be suitably trained and certificated to follow set procedures that ensure all testing can be legally defended. We provide competency courses for the following matrices:

  • Alcohol Testing
  • Instant Urine Testing
  • Instant Oral Fluid Testing

In addition to the above, we also provide a portfolio of other training and education presentations that enable employers to enhance awareness of substance misuse & understand the various processes involved when implementing a workplace testing programme. These options include:

  • Chain of Custody Training
  • Drug & Alcohol Awareness Training
  • Employee Briefings
  • Bespoke Training Courses

All training courses are fully recorded, regularly reviewed and include an assessment of the effectiveness of training. Upon completion, all attendees are granted a Certificate of Attendance at the end of each completed training course.

Randox Testing Services

Randox Testing Services are a specialist in the workplace drug & alcohol testing sector. We provide a wide range of testing for companies who want to reduce the impact of substance misuse in the workplace. With a range of service options and expert staff on hand to provide help and training, our services will help to eradicate the impact of drugs and alcohol.

If you have any questions regarding drug & alcohol testing and how we can provide your company with training and education services, please use the below details to get in touch and we will be happy to discuss requirements.

Email – testingservices@randox.com

Phone – +44 (0) 28 9445 1011

Want to know more?

Contact us or visit our website to read more.


Linearity Verifier Sets

Contact Us

Challenge your Instrument Throughout the Reportable Range with Acusera Linearity Verifier Sets

  • null
    Complimentary data reduction software is provided delivering an immediate indication of performance.
  • null
    Samples are provided in a user-friendly format with both liquid and lyophilised options available.
  • null
    An extended open vial stability keeps waste to a minimum and ensures availability of product for troubleshooting.
  • null
    Supplied in a minimum of 5 levels to accurately challenge the AMR and remove the need for manual dilution.
  • null
    Ensure specific instrument requirements are met with the availability of dedicated solution for both Roche Cobas and Beckman systems.
  • null
    Multi-analyte calibration verifiers will reduce costs, storage space and the number of products required to cover your test menu.
Solutions for Roche Cobas Analysers